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Introduction
Cycloox ygenase (COX), also know n as prostaglandin H synthase , is a membrane bound, bifunc tional enzyme that c atalyze s the conve rsion of arachidonic acid to prostaglandin G 2 by its cycloox yge nase activity and prostaglandin G 2 to prostaglandin H 2 by perox idase activity. It is the rate-limiting ste p in the biosynthesis of the biologically ac tive and physiologic ally important prostaglandins, thrombox anes and prostac yclin. COX ex ists in tw o distinct isoforms. COX-1 ex ists in most tissues and is involved in the physiological p roduc tion of prostaglandins. COX-2 has be e n demonstrated to be ex pre ssed in re sponse to many p roinflammatory stimuli such as cytokines as w ell as grow th factors.
1 ,2 Furthermore, COX-2 is thought to be the isoform re sponsible for the production of proinflammatory prostanoids in various mode ls of inflammation. The ide ntification of constitutiv e and induc ible COX e nzyme s has led to the hypothesis that COX-2 is primarily re sponsible for prostaglandins produce d in inflammation and COX-1 is involved in normal homeostasis. 3 ,4 Inflammatory bow el dise ase (IBD) is a chronic debilitatin g illness of the gastrointestinal trac t that enc ompas ses tw o p rimary forms of idiopathic inte stinal inflammation. Ulc erative c olitis is a dise as e that affec ts primarily the c olon and re ctum and involves mucosal (e pithe lial) inflammation, w hile Crohns disease affec ts the GI trac t from mouth to anus and involves transmural inflammation, including the mucosal and muscle layers. As a re sult of the amplification of the inf lammatory proc ess, soluble me diators such as eic osanoids play a significant role in the pathoge ne sis and progression of IBD. 5 Production of eic osanoids are inc re as ed in gut muc osa in active IBD, w he the r assessed by in v itro c ulture of mucosal biopsie s, in v ivo re c tal dialysis, or w hole-gut lavage . 6 ,7 The production of p rostaglandins de clines in IBD patients treated w ith either c ortic oste roids or sulfasalazine . Although prostaglandin le ve ls in mucosal spec imens of IBD patients decline s w hen the y are tre ate d w ith NSAIDs, there is no clinic al improve ment. In one study, se le ctive COX-2 antagonists w e re show n to ex ace rbate colitis. 8 Human inte stinal smooth muscle ce lls play a major role in the re pair of injured inte stine . This proce ss appears to be me diate d by c ytokine s such as interleukin-1B w hich induc es c ollagenase ex pre ssion and inhibits collage n ex pre ssion in human intestinal smooth muscle c ells.
9 ,10 A common feature of Crohn's disease is a narrow ing or stric turing of the bow el lumen. Stric ture formation re mains a clinically important complication of Crohn's disease . Previous studies have de monstrated that IL-1B e nhanc es prolife ration of smooth muscle ce lls sugge sting that the cytokine produce d during chronic inflammation may contribute to inte stinal stric ture formation.
11
Selec tive COX inhibitors are currently available. In pre vious studies, utilizing spe cific COX-1 and COX-2 inhibitor s, it has be en found that selec tive COX-1 and/ or COX-2 inhibitors variably inhibit ce ll prostanoid formation stimulate d by c ytokine s depe nde nt on the ce ll type and the stimulus.
12 -1 4 Proliferation of both non-transformed epithelial cells and malignant inte stinal ep ithe lial c ells w as inhibite d by spec ific COX-2, but not COX-1 inhibitors, 1 5 indicating a role for COX in mitogene sis as w e ll as de monstrating the role of COX in prostanoid produc tion by proinflammatory age nts in various c ells such as enterocyte s, 1 2 colonocytes 1 4 and gallbladder c ells. 13 Limited information ex is ts re garding the ac tivity of COX enzymes in human inte stinal smooth muscle ce lls. 11 In the pre sent study, the e ffec t of se lec tive COX-1 and COX-2 inhibitors on IL-1 and LPS stimulate d prostanoid re le as e by intestinal smooth muscle c ells w as e valuated. It w as also inte nded to asc ertain if COX e nzyme s play a role in the re plication of human intestinal smooth muscle c ells.
Methods

Cell isolation and culture
Human Intestinal Smooth Muscle c ells (HISM, c atalogue #1692-CRL) obtained from the American Type Culture Collec tion (Rockville, MD) w e re maintain e d at 37°C in an atmosphe re of 5% CO 2 and 100% re lative humidity. Ce lls w e re split at a ratio of 1: 2 up on re aching confluenc e. Ce lls w ere detached using 0. 
Materials and protocol
The cells w e re plated at a de nsity of 13 10 6 
Western blot analysis
Ce lls w ere se eded into 100 mm dishe s (1.5 3 10 6 /dish) and grow n to c onfluenc y for 2 days. The cultures w ere rinse d w ith se rum-fre e medium and
inc ubate d w ith media alone or w ith IL-1b or LPS for 8 h. At the conclusion of the ex periments the c ells w ere lyse d w ith 1% Triton X-100, 120 mM sodium chloride, 25 mM HEPES (pH 7.4), 1 mM phenylme thylsulfonyl fluoride, 10 m g/ml le upe ptin, 10 m g/ml apoprotinin and 10 m g/ml antipapain. After 30 min the ex trac ts w ere ce ntrifuge d at 12,000 g for 10 min and the supernatants solubilized w ith SDS-PAGE buffer (68 mM Tris-HCl, pH 6.8, 5% B-me rc aptoe thanol, 2% SDS, and 10% glyc erol). The samples w ere boiled for 5 min and equal amounts w ere applie d to a 10% SDS-polyacrylamide gel. Proteins w ere transferred to nitroc ellulose and then inc ubate d overnight in Tris-buffe re d saline, 0.2% Tw een-20, and 10% nonfat dry milk (BLOTTO). The me mbrane s w ere inc ubate d w ith a rabbit antiserum gene rated against murine COX-2 (1:1000) or she ep COX-1 (1:1000). Follow ing a thre e-hour incubation at 37°C, the membrane s w ere w ashed w ith BLOTTO and incubated w ith goat anti-rabbit IgG conjugate d to horse radish perox idase (1:1000, Cappe l) for 3 min at 37°C. Immunore active prote ins w e re visualized using the enhance d che miluminesc enc e (ECL®, Amersham) me thod.
Eicosanoid measurements
To de te rmine the ce ll prote in c oncentration pe r w e ll the w e lls w ere thaw ed and w as he d w ith KRB buffer. 
Proliferation studies
For the proliferation ex periments 13 10 3 c ells w ere se eded onto 96 w ell c ulture plate s (Costar, Cambridge, MA) in 100 m l of Dulbelc co's minimum essential me dium (DMEM, Sigma, St Louis, MO) w ith or w ithout 10% fe tal bovine serum (FBS, Sigma). After 24 h at approx imately 70% c onfluenc y, the c ells w e re treate d w ith e ithe r the COX-1 inhibitor VSA (Cayman, Ann Arbor, MI), the COX-2 inhibitor SC-58125 (Monsanto/ Searle, St Louis, MO) or indome thacin (Sigma, St Louis, MO). Afte r 24 h of ex posure the ce lls w ere w ashe d w ith phosp hate-buffe re d saline (PBS, Sigma) and tre ate d w ith the same types of media and age nts, including 1.5 uCi/w e ll 3 H-thymidine (ICN, Costa Mesa, CA) for 7 h. The ce lls w ere lyse d w ith 100 ml of 0.1 M NaOH and 0.2% Triton X-100 (Sigma) and the lysates pre c ipitated w ith 20% trichloroace tic acid (TCA, Sigma). The pre c ipitates w ere the n harveste d in 5% TCA onto 240-1 glass-fiber filte rs (Cambridge , Wate rtow n, MA). The amount of isotope incorporated into DNA w as dete rmine d by liquid sc intillation counting using a Beckman LS 100 instrument.
Statistical analysis
The data is pre sented as mean± SEM. Statistic al analysis w as performed by analysis of the varianc e. Differe nc es be tw een groups w ere dete rmine d by the least significant differe nc e. As used throughout the manuscript 'signific ant' indic ates p< 0.05.
Results
Western analysis
Weste rn blotting of re sting c ells (me dium alone ) demonstrate d both constitutiv e COX-1 and COX-2 prote in. Whe n c ells w ere incubated w ith LPS or IL-1b for pe riods of up to 24 h, the re w as no inc re as e in ex pre ssion of COX-2 prote in. How ever, after 8 h of LPS or IL-1b treatme nt, COX-1 ex p re ssion w as inc re as ed (Fig. 1) . markers w e re run on the same gels and the COX immunore ac tive bands show n corresp onded to prote ins ap prox imately 70 kDa in size c onsiste nt w ith COX enzymes. The se re sults suggest that both COX-1 and COX-2 prote in w e re both pre sent constitutiv ely and COX-1 w as further upre gulated by proinflammatory stimuli.
Basal prostanoid formation
Whe n unstimulate d HISM c ells w e re evaluate d, the ce lls p roduc ed both PGE 2 and PGI 2 , the latter e valuate d by me asuring 6-ke to-PGF1a (Table 1 ). The HISM c ell line produce d significantly more PGE 2 than 6-ke to-PGF1a . In unstimulate d HISM ce lls, VSA, SC-58125 and NS-398 inhibited both PGE 2 and 6-ketoPGF1a formation, suggesting that both is oforms contribute to basal p rostanoid le vels (Table 1) . Basal LTB 4 le ve ls w e re unaffe cte d by COX inhibition.
Stimulated prostanoid formation
The proinflammatory stimulant IL-1b produce d conce ntration re late d incre ase s in PGE 2 formation by HISM ce lls (Fig. 2) . The incre ase in PGE 2 produc ed by IL-1b w as also time de pendent w ith the max imum production seen at 8 h (Fig. 3 ). IL-1b (100 units/ml) and LPS (100 m g/ml) stimulate d PGE 2 production by HISM cells c ompared to c ontrol values (Tables 2 and  3 ). VSA, SC-58125 and NS-398 significantly dec re as e IL-1b and LPS stimulated PGE 2 produc tion (Tables 2  and 3 ). LPS and IL-1b both also signific antly incre ase d prostacyclin formation as e videnc ed by incre ase s in the stable metabolite of prostac yclin, 6-KPGF 1a (Table s 2 Each value represents the mean ±SEM of six values obtained from the mean of duplicate measurements of prostanoids in the buffer solution from six tissue culture wells containing 13 10 6 HISM cells. The cells were exposed to the cytokines with or without the COX inhibitors for four hours. Asterisk indicates that the stimulated value is significantly different from the control value. The # sign indicates that the COX inhibitor significantly altered the value stimulated by the cytokine. HISM ce lls grow n in 10% FBS sugge sting that both COX-1 and COX-2 enzymes may c ontribute to human smooth muscle c ell p roliferation .
Discussion
This study ex amine d the induction by IL-1 and LPS of COX protein and the e ffec t of sele ctive COX antagonists on p rostanoid formation and on c ell prolife ration in a human gut derived smooth muscle ce ll line. This ce ll line appe ars to be a use ful mode l for studying the production of prostanoids by smooth muscle cells during inflammatory states. Previous studie s from our laboratory employing gas trointestinal e pithe lial cells have show n that trinitrob e nze ne sulfonic ac id (TNB), a hapte n w hich p roduc es ex p erimental colitis, led to significant inc re as es in PGE 2 and 6-ke to PGF1 a re lease , but not leukotriene re le as e; re sponses w hich w ere inhibited by indome thac in. 17 In the pre se nt study, IL-1b and LPS stimulate prostanoid production in HISM c ells w hich w as inhibited by se lective COX inhibitor s. To investigate the me chanism by w hich IL1b and LPS e nhance the produc tion of PGE 2 and 6-ke to PGF 1 a in the HISM c ell, w e analyze d the ex pre ssion of both COX-1 and COX-2 protein following tre atment. We found that IL-1b and LPS re sulted in the rap id and transie nt induction of both the COX-1 and COX-2 is oform. Othe r investigators have ex amined the induc tion of COX is oforms in smooth muscle ce lls othe r than those that are gut derived. Incre ase d levels of se veral pro-inflammatory c ytokine s including IL-1 and TNF have be e n found in bronchoalve olar lavage f luid from symptomatic asthmatic patients. The effe cts of IL-1b , TNF and IFN on the induction of COX isoforms in cultured human airw ay smooth muscle c ells demonstrate d that only IL-1b produce d a time and conc entration depe nde nt enhancement of PGE 2 and 6-keto PGF 1a and a corresp onding incre as e in COX-2, but not COX-1 ac tivity. Pre treatme nt w ith conve ntional NSAIDs and se lective COX-2 inhibitors complete ly blocked IL-1b induc ed PGE 2 re leas e and both glucocortic oids and prote in synthesis inhibitors suppre sse d IL-1b induc ed COX-2 induction. This sugge sts that airw ay smooth muscle may be an important source of prostaglandins in human airw ays and that COX-2 may play an imp ortant role in the re gulation of the inflammatory process in as thma. 1 8 A similar study demonstrate d that COX-2 ex pre ssion and PGE 2 formation w e re inhibite d by an IL-1 re ce ptor antagonist. 1 9 Both studies sugge st that IL-1b produce d PGE 2 formation in human bronchial smooth muscle cells that is mediate d by de n o vo ex pre ssion of COX-2 enzyme.
The metabolism of arachidonic acid and production of eicosanoids plays a vital role in the function of the ce ntral ne rvous syste m, e spec ially the ce re brovascular function. Smooth muscle c ells isolated from murine c ere bral microve sse ls produc ed primarily PGE 2 and PGI 2 in re spons e to ex ogenous arachidonic acid and c alc ium ionophore . Serum de privation of smooth muscle c ells caused an 80-90% diminution in both PGE 2 and PGI 2 , w hich w as re store d w ith the re introduction of serum w ithin 6 h. COX-1 and COX-2 mRNA w as dete ctable in smooth muscle c ells grow n in the pre se nce of serum, but COX-2 mRNA w as not pre sent in serum de prive d ce lls. Readdition of serum induc ed a massive inc re as e in COX-2 mRNA w ith only a small incre ase in COX-1 mRNA. 20 Culture d rat aortic smooth muscle c ells ex hibited a 45-fold inc re ase in COX-2 mRNA le ve ls afte r 2 h ex posure to serum. This w as associate d w ith inc re as ed COX-2 prote in and a 3-fold inc re ase in PGE 2 .
21 COX-1 prote in is pre sent in freshly is olated myometrial c ells and is not affec te d by tre atment w ith IL-1. Constitutiv e COX-2 is also p re sent and is unregulate d by IL-1b tre atment. Both basal and IL-1b stimulated incre ase in COX-2 w ere re duce d by both a prote in synthesis inhibitor and an inhibito r of transc rip tion. 22 The possible re lations hip of COX e nzymes, prostanoids, spec ific COX-1 and COX-2 inhibitors and standard NSAIDs to dec re as ing the rate of de ve lopme nt of gas trointestinal cance r is currently an ac tive are a of investigation. Pre vious w ork from our laboratory has demons trated that in both nonmalignantand malignant-derived murine intestinal epithelial ce ll lines the re w as e videnc e that the prolife ration of ce lls, stimulate d by serum, w as influe nce d by COX-2, but not COX-1 e nzyme . 15 The se re sults c onfirm pre vious in vitro studies de monstrating the inhibition of c ell proliferation by spec ific COX-2 inhibitors. 2 3 -26 These ex perime ntal re sults support a role for COX-2 in intestinal epithe lial c ell mitogene sis and provide d ground w ork for similar studie s w ith smooth muscle c ells. Unlike that seen w ith intestinal epithe lial c ells, prolife ration of HISM ce lls appears to have variable contributions from both COX-1 and COX-2.
Crohn's disease is an idiopathic , chronic inflammation of the gastrointestinal tract that c ause s narrow ing and stricturing of the small and large intestine. Although the me chanisms by w hich chronic inflammation p romote s stricture formation re main ill defined, it does appe ar to be assoc iated histologically w ith a hyperplasia of smooth muscle cells and an inc re as ed de position of c ollagen w ithin the bow e l w all. The proinf lammatory c ytokines IL-1b caused a significant dose -de pendent incre ase in intestinal smooth muscle ce ll prolife ration. 2 7 This sugge sts that proinflammatory c ytokine s produce d during chronic inflammation may enhance the proliferation of smooth muscle c ells and may contribute to the narrow ing and stric turing observe d in Crohn's disease . Smooth muscle ce lls in the intestinal w all play a significant role in the healing of the injured intestine and in the fibrosis that complicates Crohn's diseas e. 2 7 IL-1b is mitoge nic for human intestinal smooth muscle c ells and is assoc iate d w ith a concomitant dow n re gulation of c ollagen synthe sis and se cre tion and an augmentation of collegenase ex pre ssion. 2 8 Cortic oste roids re pre ss the induction of collage nase ex pre ssion and the inhibition of collage n secre tion by IL-1b in HISM ce lls. We fe el that based on our pre liminary w ork, selec tive COX inhibition may be a pote ntial ave nue for addressing the p roble m of stric ture formation such that changes in prostanoid milleu or e ven smooth muscle ce ll mitogene sis may either delay or ame liorate progre ssion of intestinal Crohn's disease .
The ro le o f COX in pro s ta n o id fo rm a tio n
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